Trial intelligence / Profile preview

Clinical observation of different induction schemes of general anesthesia in elderly patients

ChiCTR2000040133Phase 4Not yet recruiting

Sponsor
Tianjin Fourth Central Hospital
Start
Dec 2020
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of sufentanil and esketamine (4 arms), sponsored by Tianjin Fourth Central Hospital. Primary endpoint: Efficacy evaluation. Planned start Dec 2020; status: not yet recruiting.

02

Drugs

sufentanilesketamine

Beyond the preview

Go deeper on ChiCTR2000040133.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000040133.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call